Volume 126, Issue 17 pp. 4493-4496
Zuschrift

Application of Fundamental Organometallic Chemistry to the Development of a Gold-Catalyzed Synthesis of Sulfinate Derivatives

Miles W. Johnson

Miles W. Johnson

Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 (USA)

Search for more papers by this author
Scott W. Bagley

Scott W. Bagley

Pfizer Worldwide Medicinal Chemistry, Groton, CT 06340 (USA)

Search for more papers by this author
Prof. Neal P. Mankad

Prof. Neal P. Mankad

Department of Chemistry, University of Illinois at Chicago (USA)

Search for more papers by this author
Prof. Robert G. Bergman

Prof. Robert G. Bergman

Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 (USA)

Search for more papers by this author
Dr. Vincent Mascitti

Corresponding Author

Dr. Vincent Mascitti

Pfizer Worldwide Medicinal Chemistry, Groton, CT 06340 (USA)

Vincent Mascitti, Pfizer Worldwide Medicinal Chemistry, Groton, CT 06340 (USA)

F. Dean Toste, Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 (USA)

Search for more papers by this author
Prof. F. Dean Toste

Corresponding Author

Prof. F. Dean Toste

Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 (USA)

Vincent Mascitti, Pfizer Worldwide Medicinal Chemistry, Groton, CT 06340 (USA)

F. Dean Toste, Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 (USA)

Search for more papers by this author
First published: 20 March 2014
Citations: 68

This research was supported in part by a grant from the NIHGMS (RO1 GM073932). M.W.J. is grateful to the National Science Foundation (no. DGE1106400) and UC Berkeley for pre-doctoral research fellowships. N.P.M. acknowledges the National Institute of Health for a Kirchstein-NRSA postdoctoral fellowship. S.W.B. thanks Andrei Shavyna, Aaron Smith, and Kevin Hesp for helpful discussions. William J. Wolf (UC Berkeley) and Brian Samas (Pfizer) are thanked for assistance with X-ray crystallographic studies.

Abstract

The development of a gold(I)-catalyzed sulfination of aryl boronic acids is described. This transformation proceeds through an unprecedented mechanism which exploits the reactivity of gold(I)–heteroatom bonds to form sulfinate anions. Further in situ elaboration of the sulfinate intermediates leads to the corresponding sulfones and sulfonamides, two pharmacophores routinely encountered in drug discovery.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.